← FDA Drug Approvals (Drugs@FDA)

XYZAL

NDA · New Drug Application · Sponsor: CHATTEM SANOFI · Approved 2008-01-28

Drug application

FDA Application #

NDA022157

Application type

New Drug Application

Brand name

XYZAL

Generic name

Levocetirizine Dihydrochloride

Active ingredients

LEVOCETIRIZINE DIHYDROCHLORIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

CHATTEM SANOFI

First approval

2008-01-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown